Kang, Soosung Professor
Pharmaceutical Sciences/Division of Pharmacy/Industrial Pharmaceutical Science
Dr. Kang is engaged in the development of new drugs, employing medicinal chemistry, computational chemistry, and organic chemistry, as a faculty member at the College of Pharmacy, Ewha Womans University. He earned his Ph.D. in Organic Chemistry/Medicinal Chemistry from Purdue University in the United States in 2009, under the guidance of Professor Lipton. Subsequently, until 2014, he served as a research associate at the Silverman group at Northwestern University in the United States, conducting diverse research on central nervous system drug development. From 2014 to 2017, he held the position of principal researcher at the New Drug Development Center, K-Med Hub, contributing to research on treatments for Alzheimer's disease, inflammatory diseases, and anticancer agents. Since March 2017, he has been serving as a professor at his current university. Currently, his research focuses on the innovative development of therapeutics for neurodegenerative diseases, inflammation, and antibiotics, particularly targeting mitochondrial-involved conditions. He employs tools from medicinal chemistry, organic chemistry, computational chemistry, and chemical biology for this endeavor.
- Director, Global AI Drug Discovery Center
- Pharmaceutical Science Building B #314
- 02-3277-6619
- Research Interests
Research Record
- Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis Journal of Medicinal Chemistry, 2023, v.66 no.23, 16342-16363
- Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model Biomedicine and Pharmacotherapy, 2023, v.157, 114072
- Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity Molecules (Basel, Switzerland), 2023, v.28 no.6
- 2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint ACS Medicinal Chemistry Letters, 2022, v.13 no.9, 1459-1467
- Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents European Journal of Medicinal Chemistry, 2022, v.244, 114837
- Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors ACS Omega, 2022, v.7 no.16, 14252-14263
- Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1 Journal of Medicinal Chemistry, 2022, v.65 no.24, 16155-16172
- Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6-chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity Bioorganic Chemistry, 2022, v.126, 105856
- Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity ACS MEDICINAL CHEMISTRY LETTERS, 2021, v.12 no.7, 1173-1180
- Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors JOURNAL OF MEDICINAL CHEMISTRY, 2021, v.64 no.2, 958-979
- Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, v.143 no.47, 19684-19696
- A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of Ca(v)1.3 L-Type Calcium Channels ACS CHEMICAL BIOLOGY, 2020, v.15 no.9, 2539-2550
- Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics Cells, 2020, v.9 no.11, 0
- Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models Bioorganic Chemistry, 2020, v.101, 103901
- Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, v.30 no.2, 126809
- Physiological involvement of presynaptic L-type voltage-dependent calcium channels in GABA release of cerebellar molecular layer interneurons JOURNAL OF NEUROCHEMISTRY, 2020, v.155 no.4, 390-402
- Practical direct synthesis of: N -aryl-substituted azacycles from N -alkyl protected arylamines using TiCl4and DBU Organic and Biomolecular Chemistry, 2020, v.18 no.26, 5008-5016
- Casein kinase-1 gamma 1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3 CELL DEATH & DISEASE, 2019, v.10, 923
- Metal-Free Synthesis of N-Aryl-Substituted Azacycles from Cyclic Ethers Using POCI3 JOURNAL OF ORGANIC CHEMISTRY, 2019, v.84 no.11, 6689-6696
- Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo [1,5-a]pyrimidin-3-yl acetamide BIOORGANIC & MEDICINAL CHEMISTRY, 2019, v.27 no.18, 4069-4080
- CF3-Substituted Mollugin 2-(4-Morpholinyl)-ethyl ester as a Potential Anti-inflammatory Agent with Improved Aqueous Solubility and Metabolic Stability MOLECULES, 2018, v.23 no.8, 2030
- Convenient metal-free direct oxidative amidation of aldehyde using dibromoisocyanuric acid under mild conditions TETRAHEDRON LETTERS, 2018, v.59 no.39, 3541-3546
- Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery MOLECULES, 2018, v.23 no.8, 1963
- Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design FRONTIERS IN PHARMACOLOGY, 2018, v.9
- Facile direct synthesis of unsymmetrical ureas from N-Alloc-, N-Cbz-, and N-Boc-protected amines using DABAL-Me-3 TETRAHEDRON, 2018, v.74 no.30, 4036-4046
- Hypervalent Iodine-Mediated Alkene Functionalization: Oxazoline and Thiazoline Synthesis via Inter-/Intramolecular Aminohydroxylation and Thioamination ADVANCED SYNTHESIS & CATALYSIS, 2018, v.360 no.4, 779-783
- Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors JOURNAL OF MEDICINAL CHEMISTRY, 2017, v.60 no.17
- Electrostatic Control of Isoform Selective Inhibitor Binding in Nitric Oxide Synthase BIOCHEMISTRY, 2016, v.55 no.26, 3702-3707
- Regulation of aldosterone secretion by Ca(v)1.3 SCIENTIFIC REPORTS, 2016, v.6, 24697
- 2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity JOURNAL OF MEDICINAL CHEMISTRY, 2015, v.58 no.14, 5548-5560
- Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase BIOCHEMISTRY, 2015, v.54 no.26, 4075-4082
- Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus CHEMISTRY & BIOLOGY, 2015, v.22 no.6, 785-792
- Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase JOURNAL OF MEDICINAL CHEMISTRY, 2015, v.58 no.21, 8694-8712
- Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease BRAIN, 2015, v.138
- Structure-Based Design of Bacterial Nitric Oxide Synthase Inhibitors JOURNAL OF MEDICINAL CHEMISTRY, 2015, v.58 no.2, 994-1004
- Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain CHEMICAL SOCIETY REVIEWS, 2014, v.43 no.19, 6814-6838
- The Mobility of a Conserved Tyrosine Residue Controls Isoform-Dependent Enzyme-Inhibitor Interactions in Nitric Oxide Synthases BIOCHEMISTRY, 2014, v.53 no.32, 5272-5279
- [학술지논문] Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis JOURNAL OF MEDICINAL CHEMISTRY, 2023, v.66 no.23 , 16342-16363
- [학술지논문] Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model BIOMEDICINE & PHARMACOTHERAPY, 2023, v.157 no.157 , 114072-114072
- [학술지논문] 2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRP alpha Checkpoint ACS MEDICINAL CHEMISTRY LETTERS, 2022, v.13 no.9 , 1459-1467
- [학술지논문] Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, v.244 no.0 , 114837-114837
- [학술지논문] Palladium-Catalyzed alpha-Arylation of Cyclic beta-Dicarbonyl Compounds for the Synthesis of Ca(V)1.3 Inhibitors ACS OMEGA, 2022, v.7 no.16 , 14252-14263
- [학술지논문] Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1 JOURNAL OF MEDICINAL CHEMISTRY, 2022, v.65 no.24 , 16155-16172
- [학술지논문] Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6--chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity BIOORGANIC CHEMISTRY, 2022, v.126 no.126 , 105856-105856
- [학술지논문] Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity ACS MEDICINAL CHEMISTRY LETTERS, 2021, v.12 no.7 , 1173-1180
- [학술지논문] Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors JOURNAL OF MEDICINAL CHEMISTRY, 2021, v.64 no.2 , 958-979
- [학술지논문] A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of Ca(v)1.3 L-Type Calcium Channels ACS CHEMICAL BIOLOGY, 2020, v.15 no.9 , 2539-2550
- [학술지논문] Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics CELLS, 2020, v.9 no.11 , 2447-2447
- [학술지논문] Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models BIOORGANIC CHEMISTRY, 2020, v.101 no.0 , 103901-103901
- [학술지논문] Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, v.30 no.2 , 126809-126809
- [학술지논문] Physiological involvement of presynaptic L-type voltage-dependent calcium channels in GABA release of cerebellar molecular layer interneurons JOURNAL OF NEUROCHEMISTRY, 2020, v.155 no.4 , 390-402
- [학술지논문] Practical direct synthesis of N-aryl-substituted azacycles from N-alkyl protected arylamines using TiCl4 and DBU ORGANIC & BIOMOLECULAR CHEMISTRY, 2020, v.18 no.26 , 5008-5016
- [학술지논문] Casein kinase-1 gamma 1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3 CELL DEATH & DISEASE, 2019, v.10 no.0 , 923-923
- [학술지논문] Metal-Free Synthesis of N-Aryl-Substituted Azacycles from Cyclic Ethers Using POCI3 JOURNAL OF ORGANIC CHEMISTRY, 2019, v.84 no.11 , 6689-6696
- [학술지논문] Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo [1,5-a]pyrimidin-3-yl acetamide BIOORGANIC & MEDICINAL CHEMISTRY, 2019, v.27 no.18 , 4069-4080
- [지적재산권] JAK 저해제 화합물, 및 이를 포함하는 의약 조성물 Domestic : Patent , Application
- [지적재산권] JAK 저해제 화합물, 및 이의 제조방법 Domestic : Patent , Registration , 제10-2034538호, 2019
Courses
-
2023-2nd
-
Pharmaceutical Synthesis Ⅲ 강의 계획서 상세보기
- Subject No 33948Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Thu 2~2 (PHM-A104)
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ 강의 계획서 상세보기
- Subject No 33948Class No 02
- 4Year ( 1.5Credit , 1.5Hour) Fri 3~3 (PHM-A104)
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ 강의 계획서 상세보기
- Subject No 33948Class No 03
- 4Year ( 1.5Credit , 1.5Hour) Tue 5~5 (POSCO462)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Advanced Pharmacy Practice and Research I 강의 계획서 상세보기
- Subject No 37154Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅱ 강의 계획서 상세보기
- Subject No 37155Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅲ 강의 계획서 상세보기
- Subject No 37156Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Pharmaceutical Organic Chemistry Ⅱ 강의 계획서 상세보기
- Subject No 38942Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Wed 5~5 (PHM-A404)
-
Pharmaceutical Organic Chemistry Ⅱ 강의 계획서 상세보기
- Subject No 38942Class No 02
- 2Year ( 1.5Credit , 1.5Hour) Wed 4~4 (PHM-A404)
-
Pharmaceutical Organic Chemistry Ⅱ 강의 계획서 상세보기
- Subject No 39047Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Wed 4~4 (PHM-A404)
-
Advanced Medicinal Chemistry II
- Subject No G16905Class No 01
- Year ( 3Credit , 3Hour) Tue 2~3 (PHM-)
-
Understanding and application of Bioinformatics and Chemoinformatics
- Subject No G18091Class No 01
- Year ( 3Credit , 3Hour) Fri 7~8 (PHM-)
-
-
2023-1st
-
Pharmaceutical Chemistry
- Subject No 22576Class No 01
- 3Year ( 3Credit , 3Hour) Tue 5~5 (POSCO261) , Thu 6~6 (PHM-A104)
-
Pharmaceutical Chemistry
- Subject No 22576Class No 02
- 3Year ( 3Credit , 3Hour) Tue 4~4 (POSCO) , Fri 4~4 (151)
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV 강의 계획서 상세보기
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Pharmaceutical Organic Chemistry Ⅰ 강의 계획서 상세보기
- Subject No 38931Class No 01
- 2Year ( 3Credit , 3Hour) Tue 2~2 (POSCO552) , Fri 3~3 (PHM-A104)
- Major Requisite
-
Pharmaceutical Organic Chemistry Ⅰ 강의 계획서 상세보기
- Subject No 38931Class No 02
- 2Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A104) , Fri 6~6 (PHM-A100-1)
- Major Requisite
-
Pharmaceutical Organic Chemistry Ⅰ 강의 계획서 상세보기
- Subject No 39036Class No 01
- 2Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A104) , Fri 6~6 (PHM-A100-1)
- Major Requisite
-
Introduction to Pharmaceutical Research 강의 계획서 상세보기
- Subject No 39045Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-)
-
Advanced Medicinal Chemistry I
- Subject No G16861Class No 01
- Year ( 3Credit , 3Hour) Wed 3~4 (PHM-)
-
-
2022-2nd
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Tue 4~4 (PHM-A100-1)
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 02
- 4Year ( 1.5Credit , 1.5Hour) Tue 3~3 (PHM-A100-1)
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 03
- 4Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A100-1)
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 04
- 4Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A100-1)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Advanced Pharmacy Practice and Research I
- Subject No 37154Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Advanced Medicinal Chemistry II
- Subject No G16905Class No 01
- Year ( 3Credit , 3Hour) Wed 2~3 (PHM-)
-
Understanding and application of Bioinformatics and Chemoinformatics
- Subject No G18091Class No 01
- Year ( 3Credit , 3Hour) Mon 2~3 (PHM-)
-
-
2022-1st
-
Pharmaceutical Chemistry
- Subject No 22576Class No 01
- 3Year ( 3Credit , 3Hour) Tue 2~2 , Thu 3~3
-
Pharmaceutical Chemistry
- Subject No 22576Class No 02
- 3Year ( 3Credit , 3Hour) Tue 3~3 , Thu 4~4
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 01
- 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A400) , Wed 3~3 (PHM-A400)
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 02
- 4Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A400) , Wed 4~4 (PHM-A400)
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 03
- 4Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Thu 6~6 (PHM-A400)
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 04
- 4Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Thu 6~6 (PHM-A400)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 04
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Advanced Medicinal Chemistry I
- Subject No G16861Class No 01
- Year ( 3Credit , 3Hour) Fri 5~6 (PHM-)
-
-
2021-2nd
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Tue 4~4
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 02
- 4Year ( 1.5Credit , 1.5Hour) Thu 2~2
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 03
- 4Year ( 1.5Credit , 1.5Hour) Thu 5~5
- Major Requisite
-
Pharmaceutical Synthesis Ⅲ
- Subject No 33948Class No 04
- 4Year ( 1.5Credit , 1.5Hour) Thu 5~5
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Advanced Pharmacy Practice and Research I
- Subject No 37154Class No 01
- 6Year ( 4Credit
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Advanced Medicinal Chemistry II
- Subject No G16905Class No 01
- Year ( 3Credit , 3Hour) Tue 2~3 (PHM-)
-
-
2021-1st
-
Pharmaceutical Chemistry
- Subject No 22576Class No 01
- 3Year ( 3Credit , 3Hour) Tue 4~4 , Thu 6~6
-
Pharmaceutical Chemistry
- Subject No 22576Class No 02
- 3Year ( 3Credit , 3Hour) Mon 3~3 , Thu 5~5
-
Pharmaceutical Chemistry
- Subject No 22576Class No 03
- 3Year ( 3Credit , 3Hour) Mon 3~3 , Thu 5~5
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 01
- 4Year ( 3Credit , 3Hour) Tue 2~2 , Fri 3~3
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 02
- 4Year ( 3Credit , 3Hour) Wed 4~4 , Fri 4~4
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 03
- 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 4~4
- Major Requisite
-
Pharmaceutical Synthesis Ⅱ
- Subject No 33947Class No 04
- 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 4~4
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 01
- 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 02
- 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 03
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Pharmaceutical Experiment Laboratory IV
- Subject No 37127Class No 04
- 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A309)
- Major Requisite
-
Academic Background
Purdue University Ph.D.(Chemistry)